| Germain, Doris A |
Icahn School Of Medicine At Mount Sinai
United States |
Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer. |
5R21CA270702-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Marjorie Perloff, M.D. |
| Hui, David |
University Of Tx Md Anderson Can Ctr
United States |
Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients |
5R01CA231471-05 |
|
Marjorie Perloff, M.D. |
| Bissonnette, Bruce Marc |
University Of Chicago
United States |
CXCR4 as a target for colon cancer chemoprevention |
5R01CA240710-05 |
|
Marjorie Perloff, M.D. |
| Sorror, Mohamed |
Fred Hutchinson Cancer Center
United States |
Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality |
5R01CA227092-06 |
|
Marjorie Perloff, M.D. |
| Shen, Qiang |
Lsu Health Sciences Center
United States |
Chemoprevention of Breast Cancer by Targeting Glucose Metabolism with HJC0152 |
5R01CA226001-06 |
|
Marjorie Perloff, M.D. |
| Hu, Jim |
Weill Medical Coll Of Cornell Univ
United States |
Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL) |
5R01CA259173-02 |
|
Marjorie Perloff, M.D. |
| Bissonnette, Bruce Marc |
University Of Chicago
United States |
CXCR4 as a target for colon cancer chemoprevention |
5R01CA240710-05 |
|
Marjorie Perloff, M.D. |
| Barber, Glen N. |
University Of Miami School Of Medicine
United States |
Development of A HTLV-1 Vaccine |
5R01CA252049-04 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Marjorie Perloff, M.D. |
| Hanks, Brent Allen |
Duke University
United States |
Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities |
5R01CA251136-03 |
|
Marjorie Perloff, M.D. |
| Bissonnette, Bruce Marc |
University Of Chicago
United States |
CXCR4 as a target for colon cancer chemoprevention |
5R01CA240710-05 |
|
Marjorie Perloff, M.D. |